Literature DB >> 2642432

Prevention of diabetes in BB/Wor rat by single transfusion of spleen cells. Parameters that affect degree of protection.

D Burstein1, J P Mordes, D L Greiner, D Stein, N Nakamura, E S Handler, A A Rossini.   

Abstract

Previous studies have shown that multiple transfusions of spleen cells from histocompatible nondiabetic donors prevent autoimmune diabetes mellitus in diabetes-prone (DP) BioBreeding/Worcester (BB/Wor) rats. In this study, a single transfusion of greater than or equal to 50 x 10(6) cells from either diabetes-resistant (DR) BB/Wor or Wistar-Furth (WF) rats substantially reduced the incidence of diabetes when given to DP rats 27 or 46 days old but not 61 days old. Transfusion and protection were associated with the appearance of RT6+ donor lymph node cells in recipient rats. In vivo depletion of RT6+ T-lymphocytes in 150-day-old protected animals did not produce diabetes. DR BB/Wor and WF spleen cells were equally efficacious when given either intraperitoneally or intravenously. Mitogen-activated spleen cells were relatively less effective than untreated cells. We conclude that BB rat diabetes can be prevented by one transfusion of spleen cells from histocompatible DR and WF donors, and that the protective effect is dependent on recipient age and cell dose. The effect may be mediated by a population of RT6+ T-lymphocytes that, during a critical developmental period, regulate the expression of autoimmunity in these animals.

Entities:  

Mesh:

Year:  1989        PMID: 2642432     DOI: 10.2337/diab.38.1.24

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

2.  Prevention and suppression of autoimmune pancreatic beta-cell destruction in BB rats by syngeneic lymphocytes obtained from long-term normoglycaemic donors.

Authors:  B Kuttler; A Dunger; H D Volk; T Diamantstein; H J Hahn
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

3.  Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats.

Authors:  U McKeever; J P Mordes; D L Greiner; M C Appel; J Rozing; E S Handler; A A Rossini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 4.  The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse.

Authors:  R Bortell; T Kanaitsuka; L A Stevens; J Moss; J P Mordes; A A Rossini; D L Greiner
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

5.  Ontogeny and immunohistochemical localization of thymus-dependent and thymus-independent RT6+ cells in the rat.

Authors:  D J Waite; M C Appel; E S Handler; J P Mordes; A A Rossini; D L Greiner
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Thymic epithelial defects and predisposition to autoimmune disease in BB rats.

Authors:  J Doukas; J P Mordes; C Swymer; D Niedzwiecki; R Mason; J Rozing; A A Rossini; D L Greiner
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

Review 7.  Experimental Diabetes Mellitus in Different Animal Models.

Authors:  Amin Al-Awar; Krisztina Kupai; Médea Veszelka; Gergő Szűcs; Zouhair Attieh; Zsolt Murlasits; Szilvia Török; Anikó Pósa; Csaba Varga
Journal:  J Diabetes Res       Date:  2016-08-09       Impact factor: 4.011

Review 8.  Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes.

Authors:  Yoko Mullen
Journal:  Pancreas       Date:  2017-04       Impact factor: 3.327

9.  Mercury-induced renal autoimmunity: changes in RT6+ T-lymphocytes of susceptible and resistant rats.

Authors:  L L Kosuda; D L Greiner; P E Bigazzi
Journal:  Environ Health Perspect       Date:  1993-06       Impact factor: 9.031

10.  Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes.

Authors:  J Lefkowith; G Schreiner; J Cormier; E S Handler; H K Driscoll; D Greiner; J P Mordes; A A Rossini
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.